These Numbers Could Change Investor Views For Design Therapeutics Inc (NASDAQ: DSGN)
Logos Global Management LP recently announced the acquisition of new stake in Design Therapeutics Inc (NASDAQ:DSGN). The institutional investor has increased its shareholding in the Healthcare company by 79.89% to 5.03 million shares with purchase of 2.23 million shares. This fresh investment now brings its stake to 8.99% valued currently at $13.34 million. In addition, […]
